Evidence map›Paper›PMID 37860562›Full record

ArticleHeliyon2023

MGGAN: A multi-generator generative adversarial network for breast cancer immunohistochemical image generation.

Liangliang Liu, Zhihong Liu, Jing Chang, Hongbo Qiao, Tong Sun, Junping Shang

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liangliang LiuCollege of Information and Management Science, Henan Agricultural University, Zhengzhou, Henan 450046, PR China.
Zhihong LiuCollege of Information and Management Science, Henan Agricultural University, Zhengzhou, Henan 450046, PR China.
Jing ChangCollege of Information and Management Science, Henan Agricultural University, Zhengzhou, Henan 450046, PR China.
Hongbo QiaoCollege of Information and Management Science, Henan Agricultural University, Zhengzhou, Henan 450046, PR China.
Tong SunCollege of Information and Management Science, Henan Agricultural University, Zhengzhou, Henan 450046, PR China.
Junping ShangCollege of Information and Management Science, Henan Agricultural University, Zhengzhou, Henan 450046, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immunohistochemical technique (IHC) is widely used for evaluating diagnostic markers, but it can be expensive to obtain IHC-stained section. Translating the cheap and easily available hematoxylin and eosin (HE) images into IHC images provides a solution to this challenge. In this paper, we propose a multi-generator generative adversarial network (MGGAN) that can generate high-quality IHC images based on the HE of breast cancer. Our MGGAN approach combines the low-frequency and high-frequency components of the HE image to improve the translation of breast cancer image details. We use the multi-generator to extract semantic information and a U-shaped architecture and patch-based discriminator to collect and optimize the low-frequency and high-frequency components of an image. We also include a cross-entropy loss as a regularization term in the loss function to ensure consistency between the synthesized image and the real image. Our experimental and visualization results demonstrate that our method outperforms other state-of-the-art image synthesis methods in terms of both quantitative and qualitative analysis. Our approach provides a cost-effective and efficient solution for obtaining high-quality IHC images.

Indexed as

Generative adversarial networkHematoxylin and eosinImmunohistochemical techniquesMulti-generatorPatch-based discriminator

Identifiers

PMID37860562
PMCPMC10582479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.